Moving iMage Technologies Stock (AMEX: MITQ)

Dernières nouvelles pour Moving iMage Technologies (AMEX:MITQ) Stock

Moving iMage Technologies

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation, and digital technology, as well as software solutions for operations enhancement and theatre management.

Moving iMage Technologies, Inc. Common Stock

Moving iMage Technologies Inc

To gain an edge, this is what you need to know today.
<figure class="wp-block-image size-large is-resized"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2024/09/2024-09-27_08h59_50.png" alt="" style="width:624px" /></figure>
<h3 class="wp-block-heading">Spending Disappointment</h3>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-spending-disappointment-boj-carry-trade-smci-mc-09272024">click here</a> for an enlarged chart of Super Micro Computer Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock. The chart of SMCI stock is being used to illustrate the point.</li>
<li>A fortune is to be made in artificial intelligence, but it is not going to be in a straight line. At times, it is going to be treacherous.  It is important to not make mistakes by getting carried away with the momo crowd and listening to momo gurus who have a vested interest that is not your best interest.</li>
<li>The chart shows that momo crowd favorite SMCI fell yesterday on the news of a Department of Justice (DOJ) probe due to allegations of accounting irregularities. A DOJ probe is a serious matter as it is often a criminal probe.</li>
<li>The chart shows that the enthusiasm was at its peak right after SMCI stock was added to S&amp;P 500.</li>
<li>The chart shows from the peak to the low, the stock lost 69% of its value.</li>
<li>The chart shows that the day S&amp;P 500 added SMCI stock, The Arora Report made a bold call. The Arora Report call was that SMCI was worth only $442 &#8211; $486 in the best case. The stock peaked at $1229.  As of this writing in the premarket, SMCI stock is trading at $400.95.  All Arora Report calls are 100% transparent, traceable, and auditable. Members have access to over ten years of archives, including the winners and losers – no cherry picking.</li>
<li>Right now, the momo crowd is sitting on massive losses in SMCI stock. The momo crowd was not able to distinguish between NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Super Micro Computer – the prevailing belief among the momo crowd was that NVDA and SMCI were the same.</li>
<li>The U.S. economy is 70% consumer based. For this reason, prudent investors pay attention to personal income and personal spending.  Just released personal income and spending data is disappointing.  Here are the details of the new personal income and spending data:
<ul>
<li>Personal income came at 0.2% vs. 0.4% consensus.</li>
<li>Personal spending came at 0.2% vs. 0.3% consensus.</li>
</ul>
</li>
<li>PCE is the Fed&#8217;s favorite inflation gauge.&nbsp; Here are the details:
<ul>
<li>PCE came at 0.1% vs. 0.1% consensus.</li>
<li>Core PCE came at 0.1% vs. 0.2% consensus.</li>
<li>In The Arora Report analysis, the data is in line with expectations. As such, this data should have no impact on the stock market.</li>
<li>Even though the stock market pays a lot of attention to PCE, in The Arora Report analysis, economists have become really good at projecting PCE.&nbsp; As such, investors&#8217; expectations, in general, should be that PCE will come in line with consensus.</li>
</ul>
</li>
</ul>
<h3 class="wp-block-heading">Japan</h3>
Bank of Japan (BOJ) actions are very important for U.S. investors. The reason is the carry trade.  In carry trade, funds borrow in yen and invest in the U.S. stock market. Lately, they have been buying AI stocks. Japan's ruling party LDP has chosen Shigeru Ishiba as its new leader. Ishiba is the next prime minister of Japan. In The Arora Report analysis, yen is rallying on the news as Ishiba is a supporter of BOJ.
In The Arora Report analysis, this development is negative for the carry trade and positive for the yen position using ETF Invesco CurrencyShares Japanese Yen Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXY#NYSE">FXY</a>) in The Arora Report&#8217;s ZYX Allocation.
<h3 class="wp-block-heading">Magnificent Seven Money Flows</h3>
In the early trade, money flows are positive in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In the early trade, money flows are neutral in Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and NVDA.
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h3 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h3>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).  The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).  The most popular ETF for oil is United States Oil ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>).
<h3 class="wp-block-heading">Bitcoin</h3>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is on track to have the best September ever.
<h3 class="wp-block-heading">Protection Band And What To Do Now</h3>
It is important for investors to look ahead and not in the rearview mirror.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h3 class="wp-block-heading">Traditional 60/40 Portfolio</h3>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Market Summary

Economics

Markets

Trading Ideas

General

$BTC

AAPL

AMZN

GOOG

MSFT

NVDA

SMCI

TSLA

Personal Income And Spending Disappoint, Super Micro Computer Lesson, BOJ Supporter As Japan PM

WIIM

SMMT

Summit Therapeutics shares are trading lower after Citigroup downgraded the stock from Buy to Neutral but raised its price target from $19 to $23.

Goldman Sachs analyst Kate McShane maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Buy and raises the price target from $876 to $995.

News

Price Target

Analyst Ratings

COST

Goldman Sachs Maintains Buy on Costco Wholesale, Raises Price Target to $995

MP Materials shares are trading higher after Baird raised its price target on the stock from $20 to $25.

Wells Fargo analyst Roger Read maintains BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) with a Equal-Weight and lowers the price target from $39 to $35.

Wells Fargo Maintains Equal-Weight on BP, Lowers Price Target to $35

Legal

CHWY

SEC Says Former Chewy Executive Conducted Insider Trading In 2021

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

Shares of Macau-linked casino and gaming stocks are trading higher possibly amid continued strength following a report suggesting China will issue up to $284 billion of sovereign debt as part of a stimulus.

Wells Fargo analyst George Kelly maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Equal-Weight and raises the price target from $800 to $850.

Wells Fargo Maintains Equal-Weight on Costco Wholesale, Raises Price Target to $850

Struggling chipmaker Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)&nbsp;continues to receive <a target="_blank" href="https://www.benzinga.com/news/24/09/40968128/qualcomm-reportedly-eyes-potential-takeover-of-intel-amid-60-stock-decline-but-antitrust-concerns-lo" rel="noreferrer noopener">takeover proposals from</a> chip companies, the latest being Arm Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) following Qualcomm Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) proposal earlier.
Arm Holdings recently proposed to acquire Intel&#8217;s product unit. However, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-09-27/arm-rejected-by-intel-after-approaching-it-about-buying-product-unit?sref=TBDibEcD" rel="noreferrer noopener">reports</a> that Intel is not looking to sell the business division.
Intel stock plunged 31% as it failed to capitalize on the artificial intelligence shift, which is something that contract chipmaker Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) excelled at.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/09/41012678/super-micro-unveils-next-gen-servers-powered-by-intels-latest-xeon-chips" rel="noreferrer noopener">Super Micro Unveils Next-Gen Servers Powered by Intel&#8217;s Latest Xeon Chips</a>
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="750" height="650" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27091711/newplot-1-7.png" alt="" class="wp-image-569782" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27091711/newplot-1-7.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27091711/newplot-1-7-300x260.png 300w" sizes="(max-width: 750px) 100vw, 750px" /></figure>
Meanwhile, some reports indicated Intel&#8217;s plans to convert its <a target="_blank" href="https://www.benzinga.com/news/24/09/40897994/whats-going-on-with-intel-stock-on-tuesday" rel="noreferrer noopener">foundry business into</a> an independent unit, including exploring a spinoff into a publicly traded company. The chipmaker also explored divesting stake in the programmable chip unit&nbsp;Altera.
However, Intel&#8217;s recent big wins included a&nbsp;U.S. chipmaking deal from&nbsp;Amazon.Com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web services and the U.S. Chip grant.
The chipmaker also clarified that it would not divest a majority stake in the struggling <a target="_blank" href="https://www.benzinga.com/news/24/09/40941075/whats-going-on-with-autonomous-driving-stock-mobileye-thursday" rel="noreferrer noopener">Israeli autonomous driving company</a> Mobileye Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>), whose stock is down 66% in the last 12 months.
Intel&#8217;s exploration of stake sales to companies like Qualcomm and Arm could hinder its U.S. subsidy over antitrust grounds, the Financial Times <a target="_blank" href="https://www.ft.com/content/ff0ca77d-ad35-45ba-a493-201a26932efb" rel="noreferrer noopener">reports</a>.
Multiple deals including Nvidia&#8217;s proposal to snap Arm Holdings from&nbsp;Softbank Group Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>) and Intel&#8217;s&nbsp;Tower Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSEM#NASDAQ">TSEM</a>) deal have succumbed to global regulatory opposition.
The semiconductor sector had a good week, buoyed by the <a target="_blank" href="https://www.benzinga.com/news/earnings/24/09/41046485/whats-going-on-with-nvidia-braodcom-intel-and-other-chip-stocks-on-thursday" rel="noreferrer noopener">key rate cuts</a> in the U.S. and China, an upbeat quarterly print from Micron Technology, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), and continued AI investments from Big Tech companies.
Semiconductor ETFs, Invesco Semiconductors ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSI#NYSE">PSI</a>) and SPDR S&amp;P Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XSD#NYSE">XSD</a>), gained 5%- 7% in the last five days.
Price Action: INTC stock is down 0.04% at $23.91 at the last check on Friday.
Photo via Shutterstock

Tech

Media

INTC

MBLY

PowerShares Exchange-Traded Fund Trust Dynamic Semiconductor Portfolio

QCOM

SFTBF

SFTBY

TSEM

What's Going On With Intel Stock On Friday?

Politics

Multiple Blasts Heard In Beirut, According To Reuters Witness, 'Massive Thick Clouds Of Smoke' Rising From City

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) with a Buy and maintains $10 price target.

Reiteration

LXRX

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $10 Price Target

On CNBC: Tanger Outlet CEO Discusses Shopping Trends, Consumer Demand

GDRX

PETS

Shares of pharmacy stocks are trading higher. Costco on its earnings call said pharmacy had the strongest sales percentage increase within ancillary businesses, with a double-digit script count growth, which could possibly be lifting the sector.

High-rolling investors have positioned themselves bullish on McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MCD often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for McDonald's. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 12% bearish. Among all the options we identified, there was one put, amounting to $107,640, and 7 calls, totaling $441,864.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $145.0 and $440.0 for McDonald's, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in McDonald's's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to McDonald's's substantial trades, within a strike price spectrum from $145.0 to $440.0 over the preceding 30 days.
<h3>McDonald's Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727450251_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$163.9</td>
<td>$161.1</td>
<td>$162.7</td>
<td>$145.00</td>
<td>$113.8K</td>
<td>1</td>
<td>7</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$136.9</td>
<td>$132.5</td>
<td>$134.55</td>
<td>$440.00</td>
<td>$107.6K</td>
<td>0</td>
<td>8</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$2.9</td>
<td>$2.72</td>
<td>$2.9</td>
<td>$305.00</td>
<td>$66.7K</td>
<td>2.4K</td>
<td>355</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/04/24</td>
<td>$3.6</td>
<td>$3.45</td>
<td>$3.53</td>
<td>$305.00</td>
<td>$66.3K</td>
<td>2.4K</td>
<td>1.1K</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$3.1</td>
<td>$2.96</td>
<td>$3.1</td>
<td>$305.00</td>
<td>$62.0K</td>
<td>2.4K</td>
<td>642</td>
</tr>
</tbody>
</table>

<h3>About McDonald's</h3>
McDonald's is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.
Following our analysis of the options activities associated with McDonald's, we pivot to a closer look at the company's own performance.
<h3>Current Position of McDonald's</h3>
<ul>
<li>With a volume of 533,349, the price of MCD is up 0.94% at $306.51. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 31 days.</li>
</ul>
<h3>What Analysts Are Saying About McDonald's</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $303.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs persists with their Neutral rating on McDonald's, maintaining a target price of $325. 
&#x2A; An analyst from TD Cowen has revised its rating downward to Hold, adjusting the price target to $280. 
&#x2A; An analyst from Citigroup persists with their Neutral rating on McDonald's, maintaining a target price of $301. 
&#x2A; Maintaining their stance, an analyst from Baird continues to hold a Outperform rating for McDonald's, targeting a price of $320. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on McDonald's, which currently sits at a price target of $290. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for McDonald's, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

This Is What Whales Are Betting On McDonald's

Whales with a lot of money to spend have taken a noticeably bullish stance on Bitdeer Technologies.
Looking at options history for Bitdeer Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 25% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $112,000 and 6, calls, for a total amount of $567,404.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $5.0 and $10.0 for Bitdeer Technologies, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Bitdeer Technologies options trades today is 6177.5 with a total volume of 10,120.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Bitdeer Technologies's big money trades within a strike price range of $5.0 to $10.0 over the last 30 days.
<h3>Bitdeer Technologies Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727450246_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.8</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$5.00</td>
<td>$285.9K</td>
<td>4.5K</td>
<td>819</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$2.45</td>
<td>$2.25</td>
<td>$2.27</td>
<td>$7.50</td>
<td>$107.1K</td>
<td>9.5K</td>
<td>740</td>
</tr>
<tr>
<td>BTDR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$0.4</td>
<td>$0.35</td>
<td>$0.35</td>
<td>$7.50</td>
<td>$81.8K</td>
<td>3.4K</td>
<td>2.3K</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.0</td>
<td>$2.3</td>
<td>$2.35</td>
<td>$10.00</td>
<td>$54.6K</td>
<td>7.2K</td>
<td>839</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$2.35</td>
<td>$2.05</td>
<td>$2.27</td>
<td>$7.50</td>
<td>$45.4K</td>
<td>9.5K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Bitdeer Technologies</h3>
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway.
Following our analysis of the options activities associated with Bitdeer Technologies, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Bitdeer Technologies</h3>
<ul>
<li>Currently trading with a volume of 830,932, the BTDR's price is up by 4.06%, now at $8.32. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 45 days.</li>
</ul>
<h3>What The Experts Say On Bitdeer Technologies</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $13.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $13. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $14. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bitdeer Technologies, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

BTDR

Bitdeer Technologies's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Cassava Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SAVA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Cassava Sciences.
This isn't normal.
The overall sentiment of these big-money traders is split between 40% bullish and 46%, bearish.
Out of all of the special options we uncovered, 11 are puts, for a total amount of $1,182,634, and 4 are calls, for a total amount of $186,612.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $10.0 to $60.0 for Cassava Sciences during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Cassava Sciences stands at 624.67, with a total volume reaching 6,170.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cassava Sciences, situated within the strike price corridor from $10.0 to $60.0, throughout the last 30 days.
<h3>Cassava Sciences Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727450241_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.05</td>
<td>$25.00</td>
<td>$452.0K</td>
<td>153</td>
<td>5</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$7.4</td>
<td>$7.35</td>
<td>$7.35</td>
<td>$30.00</td>
<td>$166.8K</td>
<td>105</td>
<td>234</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.15</td>
<td>$2.8</td>
<td>$3.15</td>
<td>$20.00</td>
<td>$164.7K</td>
<td>902</td>
<td>273</td>
</tr>
<tr>
<td>SAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$5.2</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$25.00</td>
<td>$110.7K</td>
<td>153</td>
<td>1.1K</td>
</tr>
<tr>
<td>SAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.55</td>
<td>$8.5</td>
<td>$8.55</td>
<td>$60.00</td>
<td>$85.5K</td>
<td>1.4K</td>
<td>115</td>
</tr>
</tbody>
</table>

<h3>About Cassava Sciences</h3>
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
Having examined the options trading patterns of Cassava Sciences, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Cassava Sciences</h3>
<ul>
<li>Trading volume stands at 3,473,313, with SAVA's price down by -13.12%, positioned at $27.69.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 39 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cassava Sciences with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

SAVA

Cassava Sciences Unusual Options Activity

On Friday, the FDA approved Regeneron Pharmaceuticals, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) and Sanofi SA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent&nbsp;(dupilumab) as an add-on maintenance treatment of inadequately controlled chronic obstructive pulmonary disease (COPD) and an <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g41067118/dupixent-dupilumab-approved-in-the-u-s-as-the-first-ever-biologic-medicine-for-patients-with-copd" rel="noreferrer noopener">eosinophilic phenotype</a>, generally known as &#8220;smoker&#8217;s lung.&#8221;
Dupixent is the first biologic medicine approved in the U.S. to treat these patients.&nbsp;&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40814475/sanofi-regeneron-drug-dupixent-shows-successful-treatment-of-patients-with-inflammatory-skin-dise" rel="noreferrer noopener">Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease</a>.
The FDA approval is based on data from two Phase 3 trials (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=7kKUkEN_j7dfFFaJgSlNFzKZoO4mFwp3ozmSi0rwdtS0dUmDMMLRg3ML03GEfgLzJP_Yg33hoRBP-3IabEFUjTEGB_rbTRFqm_JL_llzjsfHVLX2ednnpkFojo7lpUCTxdCo_2YiyMr0ctlswWAwXOheTav4f6f3NjyHRNKi9AkNKqyHtmSD_t9WycxSdyDJF-7MluPxoOJfAy9kkVjGMA==" rel="noreferrer noopener">BOREAS</a> and&nbsp;<a target="_blank" href="https://www.globenewswire.com/Tracker?data=6PGgHroz2kXLk3EuPbMe_MIJ-5vFWDjqk9axy8qZd2P7xQ3L3g2ASjHZ8xt1uzCTdZuMSDrpF3jIDhOGYYWxNY22Nyhv04bkd8VwfNHxSVov8kQjYXAerk1eaKGoDXJDxNmLd9JxB76ojM5ft65Yy_p10fVEAMfMBBDCl7C-sv2-eIX7C8dxYBsnfHK7AYcbsomWIUjlfALjFhRk2bqT3w==" rel="noreferrer noopener">NOTUS</a>) that evaluated the efficacy and safety of Dupixent compared to placebo in adults currently on maximal standard-of-care inhaled therapy (nearly all on triple therapy).
<ul>
<li>Patients who received Dupixent in BOREAS (n=468) and NOTUS (n=470) experienced the following outcomes, respectively, compared to placebo (BOREAS n=471; NOTUS n=465):</li>
<li>The primary endpoint is a 30% and 34% reduction in the annualized rate of moderate or severe COPD exacerbations over 52 weeks.</li>
<li>74mL and 68mL numerically greater improvements in post-bronchodilator FEV1 from baseline at week 12 compared to placebo, sustained at 52 weeks. Statistically significant improvements of similar magnitude were observed in pre-bronchodilator FEV1 from baseline at 12 and 52 weeks, a key secondary endpoint.</li>
<li>51% response in a health-related quality of life measure in both trials compared to 43% and 47% with placebo at 52 weeks.</li>
</ul>
About half of COPD patients continue to experience exacerbations despite being on triple inhaled therapy.
In the U.S., approximately 300,000 people live with inadequately controlled COPD and an eosinophilic phenotype.
Patients with an eosinophilic phenotype contribute to a ~30% increase in exacerbations and an increased risk of COPD-related re-hospitalizations within a year.
Today, China&#8217;s National Medical Products Administration also approved Dupixent&nbsp;(dupilumab) as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease characterized by <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g41063987/dupixent-dupilumab-approved-in-china-as-the-first-ever-biologic-medicine-for-patients-with-chronic" rel="noreferrer noopener">raised blood eosinophils</a>.
The approval is based on BOREAS and NOTUS Phase 3 trial results.
Price Action:&nbsp;At last check Friday, REGN stock was up 2.86% at $1,069.75, and SNY stock was up 1.49% at $57.85.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/09/41067826/federal-investigations-continue-for-psychiatric-hospital-chain-operator-acadia-healthcare-even-aft" target="_blank" rel="noreferrer noopener">Federal Investigations Continue For Psychiatric Hospital Chain Operator Acadia Healthcare Even After $20M Settlement Over False Claims Allegations</a>.</li>
</ul>

Biotech

Large Cap

Health Care

Movers

REGN

FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease

AGIO

Agios Pharmaceuticals shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform and cut its price target on the stock from $60 to $56.

Senator Ron Wyden (D-OR) introduced the Cannabinoid Safety and Regulation Act (CSRA) on Wednesday, aiming to establish a federal framework for regulating hemp-derived cannabinoids like <a href="http://benzinga.com/topic/CBD">CBD</a> and <a href="https://www.benzinga.com/markets/cannabis/24/01/36584043/real-weed-or-a-lab-high-delta-8-and-delta-9-thc-explained">Delta-8 THC</a>. The legislation seeks to protect public health by setting national standards on age restrictions, safety testing and labeling for <a href="http://benzinga.com/topic/hemp">hemp</a> products.
<h3 class="wp-block-heading">FDA To Oversee Hemp Product Safety And Access</h3>
Wyden&#8217;s CSRA proposes a national age limit of 21 for purchasing <a href="https://www.benzinga.com/markets/cannabis/24/07/39975361/hemp-derived-cannabinoids-vs-legal-cannabis-what-industry-members-are-saying-about-this-not-so-s">hemp-derived cannabinoid</a> products and mandates that all such products undergo safety and manufacturing testing to ensure clean processes. The bill empowers the Food and Drug Administration (FDA) to recall or ban cannabis products <a href="https://www.benzinga.com/markets/cannabis/24/07/39915334/a-nasty-high-experts-sound-alarm-over-soup-of-unknown-compounds-in-hemp-derived-thc-products">containing dangerous chemicals or additives</a>, ensuring truth in labeling.
&#8220;Just like the tobacco industry marketing cigarettes to young people, nobody should be slapping fun cartoons and glitzy candy wrapper packaging on cannabis products meant for adults,&#8221; Wyden <a href="https://www.wyden.senate.gov/news/press-releases/wyden-introduces-legislation-to-clean-up-hemp-market-keep-products-out-of-kids-hands">stated</a> in a press release. &#8220;A federal floor for regulation of hemp products is non-negotiable to ensure that consumers aren't put at risk by untested products of unknown origin. My legislation will ensure that adult consumers know what they're getting, and that hemp products are never sold or marketed to children.&#8221;
<h3 class="wp-block-heading">Synthetic Cannabinoids Would Face Federal Ban</h3>
The <a href="https://www.wyden.senate.gov/download/csra">legislation</a> allows states to impose their own regulations on hemp-derived products beyond the bill&#8217;s provisions. It also bans &#8220;artificially or synthetically derived cannabinoids and semi-synthetic cannabinoids,&#8221; <a href="https://www.wyden.senate.gov/imo/media/doc/cannabinoid_safety_and_regulation_act_section-by-sectionpdf.pdf">defined</a> as those produced through chemical synthesis, modification or conversion. The bill would prohibit adding cannabinoids to products containing alcohol, tobacco, nicotine or other substances that could interact with or enhance cannabinoid effects.
Synthetically derived cannabinoids like Delta-8 THC would also be federally banned. This means products containing Delta-8 THC synthesized from legal CBD would become illegal, significantly impacting their availability in state markets where they&#8217;re now being sold.
Further, the bill would establish a new FDA department, the Center for Cannabinoid Products, which would enforce bans on synthetically derived cannabinoids and regulate dosages in hemp products.
<h3 class="wp-block-heading">Industry Groups Back Wyden&#8217;s Hemp Bill</h3>
Co-sponsored by Senator Jeff Merkley (D-OR), the CSRA has garnered support from key industry groups, including the U.S. Hemp Roundtable and the National Cannabis Industry Association. 
&#8220;The hemp industry is united behind a simple, common-sense proposition: Hemp products should be robustly regulated, not the subject of a misguided prohibition,&#8221; said Jonathan Miller, general counsel at the U.S. Hemp Roundtable.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40833963/expert-calls-for-a-united-hemp-and-cannabis-front-industries-should-collaborate-and-push-for-fed">Expert Calls For A United Hemp And Cannabis Front, &#8216;Industries Should Collaborate&#8217; And Push For Federal Rules</a>
Clifford Starke, chairman and CEO of Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>), <a href="https://www.newsfilecorp.com/release/224598/Flora-Growth-Corp.-Applauds-Senator-Wyden-for-Introducing-the-Cannabinoid-Safety-and-Regulations-Act?k=cannabis">expressed</a> his support for the bill. &#8220;The introduction of the Cannabinoid Safety and Regulation Act represents a pivotal step forward for the cannabis and hemp industries. By establishing clear regulatory standards, this bill will not only protect public health and safety but also create a robust legal pathway for companies like Flora to deliver safe, high-quality cannabinoid products to adults. Importantly, it ensures that these products are rigorously tested, properly labeled, and age-restricted,&#8221; Starke <a href="https://www.newsfilecorp.com/release/224598/Flora-Growth-Corp.-Applauds-Senator-Wyden-for-Introducing-the-Cannabinoid-Safety-and-Regulations-Act?k=cannabis">stated</a> in a press release.
Wyden&#8217;s proposal emerges amid <a href="https://www.benzinga.com/markets/cannabis/24/07/39610764/intoxicating-hemp-products-face-regulatory-crackdown-across-multiple-states">growing state-level actions</a> to regulate or <a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">ban synthetic hemp products</a>. The bill aims to address regulatory gaps that have <a href="https://www.benzinga.com/markets/cannabis/24/07/39783607/how-hemp-became-americas-loophole-for-legal-highs">existed since the 2018 Farm Bill</a>, which legalized hemp production but inadvertently opened the market to unregulated, psychoactive hemp-derived products like delta-9 THC <a href="https://www.benzinga.com/markets/cannabis/23/10/35305062/hemp-derived-thc-edibles-in-nostalgic-flavors-like-saltwater-taffy-freeze-pops-now-available-nat">edibles</a> and <a href="https://www.benzinga.com/markets/cannabis/24/09/41009554/tilray-brands-launches-hemp-derived-delta-9-thc-drinks-in-key-u-s-markets">beverages</a>.
<h3 class="wp-block-heading">Congressional Delays, Potential Backlash</h3>
While the CSRA seeks to balance consumer safety with industry growth, its passage remains uncertain due to legislative gridlock in Congress, <a href="https://mjbizdaily.com/hemp-bill-introduced-in-us-senate-would-ban-synthetic-thc/">notes</a> MJBizDaily. With challenges in advancing basic funding bills, more complex legislation like the CSRA may face delays.
Furthermore, the bill could spark controversy akin to recent events in Missouri and California, where regulatory actions on hemp-derived products <a href="https://www.benzinga.com/markets/cannabis/24/09/40945349/cannabis-companies-have-missouris-governor-beat-hemp-thc-products-sales-resume-as-stricter-contr">faced legal challenges and industry backlash</a>. Critics argue that such measures might inadvertently <a href="https://www.benzinga.com/markets/cannabis/24/09/40906131/this-is-life-or-death-families-of-disabled-children-panic-over-gov-newsoms-hemp-cbd-ban-and-eval">harm patients dependent on hemp-derived CBD treatments</a> and negatively impact the hemp industry, suggesting Wyden&#8217;s proposal may encounter similar opposition.
<h3 class="wp-block-heading">Impact On Hemp Investments</h3>
For investors, the introduction of the CSRA signals potential market shifts in the hemp and <a href="http://benzinga.com/cannabis">cannabis</a> industries. Increased regulation could impact companies <a href="https://www.benzinga.com/markets/cannabis/24/08/40418137/industrial-hemps-14b-projected-growth-an-investment-opportunity-too-good-to-miss">producing hemp-derived products</a>, affecting profitability and investment opportunities.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41012794/gov-newsoms-hemp-ban-goes-into-effect-consequences-for-industry-investors-patients">Gov. Newsom&#8217;s Hemp Ban Goes Into Effect: Consequences For Industry, Investors, Patients</a></li>
</ul>
Image generated with AI tools.

Cannabis

Government

Regulations

FLGC

Synthetic Cannabinoids Could Be Federally Banned Under New Senate Bill To Regulate Hemp-Derived Products

TD Cowen analyst Oliver Chen maintains Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) with a Buy and lowers the price target from $26 to $25.

LEVI

TD Cowen Maintains Buy on Levi Strauss, Lowers Price Target to $25

Moving iMage Technologies Inc (MITQ) Q3 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest ones worth watching on Wednesday morning!



Moving stocks are new deals and contracts, earnings reports, stock offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Actelis Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/asns-stock-quote/">ASNS</a>) stock is rocketing more than 821% on a deal to <a href="https://www.nasdaq.com/press-release/actelis-receives-new-orders-supply-three-military-bases-cyber-hardened-networking">supply technology to three military bases</a>.</li>



<li>MF International (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfi-stock-quote/">MFI</a>) shares are soaring over 139% with heavy trading roughly <a href="https://www.marketwatch.com/story/mf-international-shares-more-than-double-in-trading-debut-after-ipo-607bbac5">one month after its public debut</a>.</li>



<li>ENDRA Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/">NDRA</a>) stock is surging more than 63% after falling yesterday on an <a href="https://www.investing.com/news/company-news/endra-life-sciences-sets-8-million-stock-offering-93CH-3470094">$8 million stock offering</a>.</li>



<li>WalkMe (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkme-stock-quote/">WKME</a>) shares are gaining over 43% on a <a href="https://seekingalpha.com/news/4112995-walkme-stock-leaps-after-15b-takeover-deal-with-sap?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">$1.5 billion takeover deal</a>.</li>



<li>Concord Medical Services (NYSE:<a href="https://investorplace.com/stock-quotes/ccm-stock-quote/">CCM</a>) stock is rising more than 33% with strong early morning trading.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) shares are increasing over 25% after being <a href="https://www.nasdaq.com/press-release/moving-image-technologies-mit-awarded-multi-million-dollar-contract-state-art-alamo">granted a new contract</a>.</li>



<li>Jayud Global Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/jyd-stock-quote/">JYD</a>) stock is heading more than 22% higher alongside heavy trading this morning.</li>



<li>U Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucar-stock-quote/">UCAR</a>) shares are climbing over 20% <a href="https://www.nasdaq.com/press-release/uotta-technology-be-adopted-portuguese-national-taxi-association-drive">on a deal</a> with the Portuguese National Taxi Association.</li>



<li>Stitch Fix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sfix-stock-quote/">SFIX</a>) stock is jumping more than 16% after <a href="https://finance.yahoo.com/news/stitch-fix-sfix-reports-q3-212003374.html">beating revenue estimates in fiscal Q3</a>.</li>



<li>Calidi Biotherapeutics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/cldi-stock-quote/">CLDI</a>) shares are up over 14% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318374243&amp;type=PDF&amp;symbol=CLDI&amp;cdn=26f24d99b28a708fa7751a113b343d34&amp;companyName=Calidi+Biotherapeutics+Inc.&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-06-04">warrant exercise agreement</a>.</li>
</ol><h2>10 Top Losers</h2><ol></ol><ol><li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is retreating more than 26% <a href="https://investorplace.com/2024/06/why-is-microalgo-mlgo-stock-up-162-today/">following a rally yesterday</a>.</li>



<li>SilverSun Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/ssnt-stock-quote/">SSNT</a>) shares are diving close to 23% on <a href="https://ca.finance.yahoo.com/news/insider-sale-ceo-mark-meller-070316512.html">a CEO stock sale</a>.</li>



<li>Sobr Safe (NASDAQ:<a href="https://investorplace.com/stock-quotes/sobr-stock-quote/">SOBR</a>) stock is pulling back over 21% <a href="https://investorplace.com/2024/06/why-is-sobr-safe-sobr-stock-up-83-today/">after yesterday&rsquo;s rally</a>.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) shares are tumbling more than 18% without any clear news this morning.</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) stock is taking an over 15% beating <a href="https://investorplace.com/2024/06/why-is-fresh2-group-fres-stock-up-31-today/">after climbing higher yesterday</a>.</li>



<li>Bone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/">BBLG</a>) shares are sliding more than 14% despite a lack of news today.</li>



<li>Vast Renewables (NASDAQ:<a href="https://investorplace.com/stock-quotes/vste-stock-quote/">VSTE</a>) stock is dropping over 14% today.</li>



<li>ThredUp (NASDAQ:<a href="https://investorplace.com/stock-quotes/tdup-stock-quote/">TDUP</a>) shares are falling more than 12% on Wednesday.</li>



<li>ThermoGenesis (NASDAQ:<a href="https://investorplace.com/stock-quotes/thmo-stock-quote/">THMO</a>) stock is decreasing over 12% on an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318372198&amp;type=PDF&amp;symbol=THMO&amp;cdn=06c6f2748734640b337b89e0d63957b3&amp;companyName=ThermoGenesis+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-04">updated agreement with CBR Systems</a>.</li>



<li>MingZhu Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ygmz-stock-quote/">YGMZ</a>) shares close out our pre-market stock movers down more than 12% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-june-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Moving iMage Technologies&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock is on the rise Wednesday after the cinema&nbsp;design and installation company received a new multi-million dollar contract.



According to <a href="https://finance.yahoo.com/news/moving-image-technologies-mit-awarded-110000789.html">a press release</a> from the company, it has signed on to build a new Alamo Drafthouse project for the company&rsquo;s new Georgetown. This is set to open for business this summer in Indianapolis, Ind.



Moving iMage Technologies notes that this new location will house a complete suite of its proprietary manufactured products. It will also feature 4K laser projection and full Q-sys AV distribution for clear visuals and audio.



Joe Delgado, executive vice president, sales and marketing at Moving iMage Technologies, said this about the contract.




&ldquo;The Georgetown location in Indianapolis is another example of our strong partnership with Alamo, one of North America&rsquo;s quickest-growing dine-in experience chains, and we&rsquo;re excited to be a part of this new project. This state-of-the-art cinema is the 44th Alamo site equipped by MiT, promising an unparalleled cinematic experience for local audiences.&rdquo;




<h2>MITQ Stock Movement on Wednesday</h2>



News of this deal brings with it heavy trading of MITQ shares as investors buy the stock. This has more than 52 million shares on the move as of this writing. That&rsquo;s well above its daily average trading volume of about 73,000 shares.



MITQ stock is up 60.2% as of Wednesday morning.



There are plenty of other stock market stories for readers to sink their teeth into today!



Fortunately, we have all of that news ready to go with our market coverage on Wednesday! A few examples include what&rsquo;s going on with shares of Archer Aviation&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/achr-stock-quote/">ACHR</a>), GameStop&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) and Nike&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nke-stock-quote/">NKE</a>). All of this news is available below!



<h2>More Stock Market News for Wednesday</h2>



<ul><li><a href="https://investorplace.com/2024/06/achr-stock-alert-faa-grants-archer-aviation-key-airline-status/">ACHR Stock Alert: FAA Grants Archer Aviation Key Airline Status</a></li>



<li><a href="https://investorplace.com/2024/06/heres-how-roaring-kitty-could-become-gamestop-gme-stock-fourth-largest-shareholder/">Here&rsquo;s How Roaring Kitty Could Become GameStop (GME) Stock&rsquo;s Fourth-Largest Shareholder</a></li>



<li><a href="https://investorplace.com/2024/06/nike-layoffs-2024-what-to-know-about-the-latest-european-job-cuts/">Nike Layoffs 2024: What to Know About the Latest European Job Cuts</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/why-is-moving-image-technologies-mitq-stock-up-60-today/">Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Deere (NYSE:<a href="https://investorplace.com/stock-quotes/de-stock-quote/">DE</a>) layoffs are a hot topic on Wednesday after the tractor and farm equipment company announced <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318375045&amp;type=PDF&amp;symbol=DE&amp;cdn=936da5c1741f9f6e860166cd73ae50f2&amp;companyName=Deere+%26+Company&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-05">job cuts coming in 2024</a>.



Deere let its employees know about the layoffs and then announced them to the public via a filing with the Securities and Exchange Commission (SEC). In that filing, the company notes that it is reducing jobs in its production and salaried workforce.



Deere is enacting these layoffs to help it meet strategic priorities while also reducing overlap. It will also help cut down on redundant roles and responsibilities at the company.



Deere also notes that it is expecting these layoffs to start later this year. The company says the salaried portion of the jobs cuts will take place in the third quarter of 2024. It also says these workforce reductions don&rsquo;t change its previous guidance from May 16.



<h2>Deere Layoffs Extend Trend</h2>



There have been plenty of layoffs taking place at more than just Deere recently. Many companies are working to cut operating costs as they deal with a tough economy. That includes high inflation and interest rates.



DE stock is down slightly as of Wednesday morning. That comes without much trading as only 359,000 units have changed hands. Its daily average trading volume is about 1.4 million shares.



Investors will want to keep reading for more of the most recent stock market stories today!



We have all of the hottest stock market news traders need to know about on Wednesday! That includes everything happening with shares of Moving iMage Technologies&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock, Archer Aviation&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/achr-stock-quote/">ACHR</a>) stock and GameStop&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) stock today. You can read up on all of these matters at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/why-is-moving-image-technologies-mitq-stock-up-60-today/">Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/achr-stock-alert-faa-grants-archer-aviation-key-airline-status/">ACHR Stock Alert: FAA Grants Archer Aviation Key Airline Status</a></li>



<li><a href="https://investorplace.com/2024/06/heres-how-roaring-kitty-could-become-gamestop-gme-stock-fourth-largest-shareholder/">Here&rsquo;s How Roaring Kitty Could Become GameStop (GME) Stock&rsquo;s Fourth-Largest Shareholder</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/deere-layoffs-2024-what-to-know-about-the-latest-job-cuts/">Deere Layoffs 2024: What to Know About the Latest Job Cuts</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Deere Layoffs 2024: What to Know About the Latest Job Cuts

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Hanesbrands&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/hbi-stock-quote/">HBI</a>) stock is getting a boost on Wednesday after the innerwear apparel company announced it will <a href="https://finance.yahoo.com/news/hanesbrands-signs-agreement-sell-global-114500683.html">sell the Champion brand</a>.



Hanesbrands&nbsp;has agreed to sell the Champion brand to Authentic Brands Group&nbsp;for $1.2 billion. The deal could increase to $1.5 billion if a contingent cash consideration of up to $300 million is fulfilled. This requires the brand to reach performance goals after the sale.



Hanesbrands&nbsp;notes that it will receive net proceeds of $900 million from this deal. The company says that it intends to use all of the funds gained from this sale to pay down its debts.



<h2>What This Means for HBI Stock</h2>



Hanesbrands&nbsp;says that the sale of Champion will take place in the second half of 2024. The company also intends to list it as discontinued operations in its filings starting in Q2 of the year. It will also update its guidance to adjust for the sale when it releases its Q2 results.



Steve Bratspies, CEO of Hanesbrands, said this about the sale.




&lsquo;Over the past three years, we have taken necessary actions to enhance the Company&rsquo;s operations and financial performance &ndash; returning to historical gross margins, reducing our cost structure, lowering our debt levels, and generating consistent cash flow. The successful completion of this transaction further simplifies our business, deleverages our balance sheet and enhances the Company&rsquo;s operations and financial performance.&rdquo;




HBI stock is up 5.1% as of Wednesday morning.



There are plenty of other stock market stories ready to go below!



We have all of the hottest stock market news traders need to know about on Wednesday! Among this is what&rsquo;s going on with Deere&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/de-stock-quote/">DE</a>) layoffs, why Moving iMage Technologies&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock is up today and more. All of this info is available at the following links!



<h2>More Wednesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/06/deere-layoffs-2024-what-to-know-about-the-latest-job-cuts/">Deere Layoffs 2024: What to Know About the Latest Job Cuts</a></li>



<li><a href="https://investorplace.com/2024/06/why-is-moving-image-technologies-mitq-stock-up-60-today/">Why Is Moving iMage Technologies (MITQ) Stock Up 60% Today?</a></li>



<li><a href="https://investorplace.com/2024/06/achr-stock-alert-faa-grants-archer-aviation-key-airline-status/">ACHR Stock Alert: FAA Grants Archer Aviation Key Airline Status</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/hbi-stock-hanesbrands-jumps-on-deal-to-sell-champion-brand-for-1-2-billion/">HBI Stock: Hanesbrands Jumps on Deal to Sell Champion Brand for $1.2 Billion</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

HBI Stock: Hanesbrands Jumps on Deal to Sell Champion Brand for $1.2 Billion

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!



Moving stocks this morning is heavy trading, drug approval, a clinical hold and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) stock is rocketing more than 118% alongside heavy pre-market trading.</li>



<li>Versus Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/vs-stock-quote/">VS</a>) shares are soaring over 54% with strong early morning trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) stock is surging more than 22% without any clear news on Friday morning.</li>



<li>Trinity Place (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tphs-stock-quote/">TPHS</a>) shares are increasing over 22% despite a lack of news today.</li>



<li>Geron (NASDAQ:<a href="https://investorplace.com/stock-quotes/gern-stock-quote/">GERN</a>) stock is gaining more than 21% after getting <a href="https://finance.yahoo.com/news/fda-approves-geron-rytelo-mds-082526023.html">approval for its blood disorder drug</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are rising over 16% with strong early morning trading today.</li>



<li>Braze (NASDAQ:<a href="https://investorplace.com/stock-quotes/brze-stock-quote/">BRZE</a>) stock is heading more than 15% higher alongside its <a href="https://www.nasdaq.com/press-release/braze-reports-fiscal-first-quarter-2025-results-2024-06-06">latest earnings release</a>.</li>



<li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) shares are jumping over 12% with <a href="https://investorplace.com/2024/06/short-interest-in-faraday-future-ffie-stock-falls-below-3/">falling short interest</a>.</li>



<li>Crown ElectroKinetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/crkn-stock-quote/">CRKN</a>) stock is getting a more than 12% boost are slipping yesterday.</li>



<li>ReTo Eco-Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/reto-stock-quote/">RETO</a>) shares are up over 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Biomea Fusion (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmea-stock-quote/">BMEA</a>) stock is plummeting more than 60% after <a href="https://finance.yahoo.com/news/biomea-fusion-announces-bmf-219-200500839.html">announcing a clinical hold</a>.</li>



<li>Virax Biolabs (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrax-stock-quote/">VRAX</a>) shares are diving over 20% <a href="https://investorplace.com/2024/06/why-is-virax-biolabs-vrax-stock-up-115-today/">after rallying yesterday</a>.</li>



<li>Xylo Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/xylo-stock-quote/">XYLO</a>) stock is tumbling more than 19% <a href="https://www.nasdaq.com/press-release/xylo-gix-internet-signed-mou-investment-and-merger-ai-robotics-company-2024-06-06">on merger plans</a> for a company it holds a significant stake in.</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) shares are taking an over 18% beating as it continues recent negative movement.</li>



<li>Jayud Global Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/jyd-stock-quote/">JYD</a>) stock is sliding more than 18% this morning.</li>



<li>Geovax Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/govx-stock-quote/">GOVX</a>) shares are falling over 15% on Friday.</li>



<li>36KR (NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/">KRKR</a>) stock is dropping close to 14% today.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) shares are decreasing more than 13% on Friday morning.</li>



<li>CalAmp (NASDAQ:<a href="https://investorplace.com/stock-quotes/camp-stock-quote/">CAMP</a>) stock is declining over 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318378043&amp;type=PDF&amp;symbol=CAMP&amp;cdn=15857b89629f6fd8bb5ccdef99a68bb0&amp;companyName=CalAmp+Corp.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-06">on insider selling</a>.</li>



<li>Sacks Parente Golf (NASDAQ:<a href="https://investorplace.com/stock-quotes/spgc-stock-quote/">SPGC</a>) shares close out our pre-market stock movers down more than 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318375423&amp;type=PDF&amp;symbol=SPGC&amp;cdn=84160401cba989fd4733d9364b53757e&amp;companyName=Sacks+Parente+Golf+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-05">on delisting woes</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-7th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!



Moving stocks this morning are acquisitions, earnings reports, pricings of public offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Foxo Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/foxo-stock-quote/">FOXO</a>) stock is rocketing more than 47% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318393600&amp;type=PDF&amp;symbol=FOXO&amp;cdn=2bd1b7f22a5eca4e128f551cdaab6e19&amp;companyName=FOXO+Technologies+Inc.+Class+A&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-13">on two acquisition deals</a>.</li>



<li>Chijet Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/cjet-stock-quote/">CJET</a>) shares are soaring over 32% alongside heavy premarket trading.</li>



<li>Vaxart (NASDAQ:<a href="https://investorplace.com/stock-quotes/vxrt-stock-quote/">VXRT</a>) stock is surging more than 24% after getting <a href="https://finance.yahoo.com/news/vaxart-receives-barda-funded-project-201500150.html">a $453 million award</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are gaining over 21% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318391892&amp;type=PDF&amp;symbol=KITT&amp;cdn=cd810aaaa8036c7dff56dd4a6d040684&amp;companyName=Nauticus+Robotics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-13">following an offering update</a>.</li>



<li>CuriosityStream (NASDAQ:<a href="https://investorplace.com/stock-quotes/curi-stock-quote/">CURI</a>) stock is increasing more than 20% without any clear news this morning.</li>



<li>La Rosa (NASDAQ:<a href="https://investorplace.com/stock-quotes/lrhc-stock-quote/">LRHC</a>) shares are climbing over 15% with strong early morning trading.</li>



<li>Moving iMage Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/mitq-stock-quote/">MITQ</a>) stock is heading more than 15% higher despite a lack of news this morning.</li>



<li>Adobe (NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) shares are rising over 14% <a href="https://www.cnbc.com/2024/06/13/adobe-adbe-q2-earnings-report-2024.html">on earnings results</a>.</li>



<li>PainReform (NASDAQ:<a href="https://investorplace.com/stock-quotes/prfx-stock-quote/">PRFX</a>) stock is jumping more than 14% without any apparent news this morning.</li>



<li>Molecular Partners (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/">MOLN</a>) shares are up over 13% on <a href="https://www.nasdaq.com/press-release/molecular-partners-presents-positive-preclinical-data-first-switch-darpin-candidate-0">positive preclinical data</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Nexalin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxl-stock-quote/">NXL</a>) stock is diving more than 27% following a <a href="https://www.nasdaq.com/press-release/nexalin-technology-announces-regulatory-approval-sell-nexalins-gen-2-15-ma">major rally yesterday</a>.</li>



<li>Gain Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ganx-stock-quote/">GANX</a>) shares are tumbling over 27% after <a href="https://www.nasdaq.com/press-release/gain-therapeutics-announces-pricing-110-million-public-offering-2024-06-13">pricing a public offering</a>.</li>



<li>Rezolute (NASDAQ:<a href="https://investorplace.com/stock-quotes/rzlt-stock-quote/">RZLT</a>) stock is taking a more than 18% beating with the <a href="https://www.nasdaq.com/press-release/rezolute-announces-pricing-public-offering-60-million-common-stock-and-pre-funded">pricing of a public offering</a>.</li>



<li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) shares are sliding over 17% <a href="https://www.globenewswire.com/news-release/2024/06/13/2898721/0/en/QXO-Announces-3-5-Billion-Private-Placement.html">on a private placement</a>.</li>



<li>Ostin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ost-stock-quote/">OST</a>) stock is dropping 17% without any obvious news to report.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) shares are falling more than 16% this morning.</li>



<li>Spectaire (NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/">SPEC</a>) stock is decreasing over 14% <a href="https://www.investing.com/news/company-news/spectaire-holdings-faces-nasdaq-delisting-over-market-value-93CH-3484080">as it risks delisting</a>.</li>



<li>Neo-Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/nci-stock-quote/">NCI</a>) shares are slipping more than 13% <a href="https://investorplace.com/2024/06/why-is-neo-concept-nci-stock-up-61-today/">after a rally yesterday</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is retreating over 12% <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">following a recent rally</a>.</li>



<li>Enservco (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ensv-stock-quote/">ENSV</a>) shares close out our pre-market stock movers down more than 12% as it <a href="https://www.nasdaq.com/press-release/enservco-corporation-provides-further-update-plan-regain-compliance-nyse-american">tries to avoid delisting</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Moving iMage Technologies gets new project in New Mexico

Earnings week ahead: Micron, Costco, BlackBerry, Accenture and more

Moving iMage Technologies reports Q4 results

ACHR

ADBE

ASNS

BBLG

BMEA

BRZE

BTOC

CAMP

CJET

CLDI

CNXC

CRKN

CTAS

CURI

ENSV

FFIE

FOXO

FRES

GANX

GDHG

GERN

GOVX

KAVL

KITT

KRKR

LILM

LRHC

MITQ

MLGO

MOLN

NAPA

NDRA

PRFX

PRGS

PRST

RCAT

RETO

RZLT

SCHL

SFIX

SOBR

SPEC

SPGC

SSNT

TDUP

THMO

TPHS

UCAR

UXIN

VERO

VIRX

VRAX

VSTE

VXRT

WKME

XYLO

YGMZ

ZAPP

Press Releases

Moving iMage Technologies (MiT) Announces Stock Repurchase Program and 10b5-1 Stock Trading Plan

Moving iMage Technologies Third Quarter Fiscal 2024 Results Conference Call and Webcast

Moving iMage Technologies Announces Third Quarter Fiscal 2024 Results

Moving iMage Technologies (MiT) Awarded Multi-Million Dollar Contract for State-of-the-Art Alamo Drafthouse Cinema in Indianapolis

Moving Image Technologies to Upgrade Alamo Drafthouse's Recently Acquired Richardson, Texas Location

Moving iMage Technologies to Upgrade Alamo Drafthouse's Recently Acquired Las Colinas, Texas Location

Moving iMage Technologies to Upgrade Premium Large Format Auditoriums With Immersive Sound Systems for Two Customers

Moving iMage Technologies Awarded Project for State-of-the-Art Flix Brewhouse Cinema in Albuquerque

Moving iMage Technologies Fourth Quarter and Full Year Fiscal 2024 Results Conference Call and Webcast

Moving iMage Technologies Announces Fourth Quarter and Full Year Fiscal 2024 Results

BloomZ

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Cineverse

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Global Mofy AI Limited - Class A Ordinary Shares

Global Mofy AI

Kuke Music Holding Limited American Depositary Shares, each representing one Ordinary Share

Kuke Music Hldg

Lytus Technologies Holdings PTV. Ltd. - Common Shares

Lytus Technologies Hldgs

MultiMetaVerse Holdings Limited - Class A Ordinary Share

MultiMetaVerse Holdings

Reading International Inc - Class A Non-voting Common Stock

Reading Intl

Scienjoy Holding Corporation - Class A Ordinary Shares

Scienjoy Holding

Sound Group Inc. - American Depositary Shares

Sound Group

Kartoon Studios

Comments

Moving iMage Technologies

Actualités

Dernières nouvelles pour Moving iMage Technologies (AMEX:MITQ) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL